Why DuPont and Pfizer Will Move the Dow Tomorrow

DuPont and Pfizer report their latest earnings results tomorrow morning, and given the difficulties the Dow has had recently, bad news could smack down the stock market.

Jan 27, 2014 at 12:30PM

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

For the first time in a long time, the Dow Jones Industrials (DJINDICES:^DJI) has been struggling to maintain traction over the past several days. After going more than two years without a true Dow correction, investors appear to be looking at the stock market with a glass-half-empty mentality. That will put extra pressure on DuPont (NYSE:DD) and Pfizer (NYSE:PFE) to deliver earnings results tomorrow that will allay fears about a pullback in U.S. economic growth.

In the past, DuPont has issued its press release with highlights of earnings results as early as 6 a.m. EST. A conference call is scheduled for 9 a.m. EST. Pfizer has scheduled its own 10 a.m. EST conference call, following a release that will likely come close to 7 a.m. EST.

For DuPont earnings, investors will pay the most attention to the company's ongoing plans to spin off its performance-chemicals unit from its faster-growing agricultural division. In recent quarters, the disparity in how the two units have fared has been striking, with low-margin commodity chemicals seeing extensive revenue and earnings pressure even as demand for agricultural products remains strong. Dismissing its nonagricultural businesses entirely would mean giving up on promising areas like photovoltaic solar materials, but DuPont appears more likely to continue using a surgical approach toward carving out the businesses it feels have the least potential for profitability and growth. Given high expectations for DuPont earnings growth, any shortfall in net income could give the Dow even more reason to fall. As one of the smaller blue-chip components by market capitalization, DuPont also needs to be careful about making itself so small that it invites eviction from its spot in the Dow 30.

Meanwhile, the Pfizer earnings report could also bring news on the restructuring front, as investors wonder whether the company will make further moves even after spinning off its animal-health unit. In particular, the possibility of separating Pfizer's generic-drug production division from its branded proprietary drug business could make investors more excited about the stock. Pfizer will likely see another big drop in revenue from this quarter, so shareholders aren't expecting perfection from the company. Yet amid huge competition in the pharmaceutical space, Pfizer still needs to demonstrate its ability to keep earnings up and bolster its pipeline to produces long-term growth.

At this point, it's unclear whether good news from Pfizer and DuPont would be enough to stop the Dow's recent drop. Disappointments, though, could be disastrous given the current mood among investors, and so you should be sure to watch DuPont and Pfizer when they release their earnings reports tomorrow morning.

Stop fidgeting with your portfolio
Wouldn't it be nice to hold onto the same stocks for years without worrying that they won't give you the performance you deserve? That's why our CEO, legendary investor Tom Gardner, has permitted us to reveal The Motley Fool's 3 Stocks to Own Forever. These picks are free today! Just click here now to uncover the three companies we love. 

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers